Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Contact Guenther G Steger

From: Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer

Contact corresponding author